Two pharmacy chains in Lima, Peru, already sell medicinal cannabis in 24 of their stores in Metropolitan Lima, benefiting more than 10,000 patients who require its use. Reports Noticias CBD
Once registered, they must have a medical consultation for the proper prescription of the treating physician.
The purchase will be in person and will only be attended with the medical prescription. At the moment there will be no home deliveries.
“The cannabis-derived product that we will offer to the market, through Inkafarma and Mifarma, will be an oral solution (oil) high in Cannabidiol (CBD), a substance that does not have psychotropic properties and will be offered in concentrations of 5% and 10% CBD and less than 1% THC in both concentrations. ‘
Curt Schwarz, Co-Founder & CEO of Anden Naturals, current official manufacturer of Digemid, said that this component can provide relief for different indications, most notably chronic pain, fibromyalgia and anxiety.
“This drug is an alternative for thousands of patients in the country who need to treat their diseases and chronic ailments, to whom we put at their disposal 24 locations in different districts of Lima, and we will continue to expand our coverage,” said Hernán Malpartida, Director of Affairs Corporate of InRetail Pharma (Inkafarma and Mifarma).
Since this February 16, both chains have invested more than half a million soles for the sale of medicinal and therapeutic cannabis.
The value of the product will vary depending on the degree of cannabidiol concentration.